243983-70-2Relevant articles and documents
Design and Catalyzed Activation of Tak-242 Prodrugs for Localized Inhibition of TLR4-Induced Inflammation
Plunk, Michael A.,Alaniz, Alyssa,Olademehin, Olatunde P.,Ellington, Thomas L.,Shuford, Kevin L.,Kane, Robert R.
, p. 141 - 146 (2020)
Tak-242 (resatorvid), a Toll-like Receptor 4 (TLR4) inhibitor, has been identified as a potent suppressor of innate inflammation. As a strategy to target Tak-242 to select tissue, four TLR4-inactive prodrugs were synthesized for activation via two different release mechanisms. Two nitrobenzyl Tak-242 prodrugs released the parent drug upon exposure to the exogenous enzyme nitroreductase, while the two propargyl prodrugs were converted to Tak-242 in the presence of Pd0.
SUBSTITUTED CYCLOHEXENES
-
, (2009/02/11)
Disclosed herein are substituted cyclohexene TLR4 signaling pathway modulators of Formula I, process of preparation thereof, pharmaceutical compositions thereof, and methods of use thereof.
Cycloalkene derivatives, process for producing the same, and use
-
, (2008/06/13)
The present invention provides a compound represented by the formula: wherein R represents an aliphatic hydrocarbon group optionally having substituents, an aromatic hydrocarbon group optionally having substituents, a heterocyclic group optionally having